Fingolimod Recruiting Phase 3 Trials for Disseminated Sclerosis Treatment
DB08868 (Fingolimod)| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Recruiting | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01892722 | Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis |